Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
GlobeNewswire
Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results From Its LRRK2 Program for Parkinson’s Disease
January 14, 2020 -
Fierce Biotech
Astellas teams with Adaptimmune to create CAR-T, TCR therapies
January 14, 2020 -
GlobeNewswire
Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance
January 13, 2020 -
GlobeNewswire
Orchard Therapeutics Highlights 2020 Strategic Priorities
January 13, 2020 -
GlobeNewswire
Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States
January 13, 2020 -
Lumere
Global Healthcare Exchange Announces Acquisition of Lumere
January 13, 2020 -
GlobeNewswire
Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications
January 13, 2020 -
GlobeNewswire
Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma
January 13, 2020 -
GlobeNewswire
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
January 13, 2020 -
Fierce Biotech
Ivenix taps new CEO as it brings its digital infusion pump to market
January 13, 2020 -
PR Newswire
Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC
January 12, 2020 -
BioPharma Dive
Ultragenyx boosted by trial data for 2nd gene therapy
January 10, 2020 -
Reuters
Acacia Pharma Partners With Cosmo Pharmaceuticals
January 10, 2020 -
PR Newswire
Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
January 9, 2020 -
Fierce Biotech
China’s Adagene bags $69M to advance lead immunotherapies
January 8, 2020 -
Kyruus
Kyruus Raises $42 Million in New Financing After Delivering Another Year of Record Growth
January 8, 2020 -
PR Newswire
Protenus Earned Designation as a Great Place to Work-Certified™ Company in 2019
January 8, 2020 -
PR Newswire
Health Action Council Partners with Buoy to Help Patients Find the Right Care
January 7, 2020 -
STAT
Apellis Pharmaceuticals’ drug candidate outperforms Alexion’s Soliris in a clinical trial comparing the two
January 7, 2020 -
PR Newswire
Sirnaomics and Innovent Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining STP705 and Sintilimab in the US
January 7, 2020 -
PR Newswire
Benchling More than Doubles Customer Base for the Second Consecutive Year
December 19, 2019 -
PR Newswire
Firefly Health and PhysicianOne Urgent Care Announce Partnership, Building a Value-Based Clinical Network for Exceptional Patient Care
December 19, 2019 -
Business Wire
Turnstone Biologics Announces Global Collaboration and License Agreement with Takeda to Develop Novel Viral Immunotherapies
December 19, 2019 -
PR Newswire
Vynca and PatientPing Announce Partnership to Integrate Advance Care Plans Into Real-Time Care Collaboration Platform
December 17, 2019 -
Indalo Tx
Indalo Therapeutics Appoints Healthcare Industry Veteran and Serial Entrepreneur Michael Heffernan as Board Chair
December 17, 2019 -
MedCity News
CommonSpirit Health taps startup (Notable Health) to reduce administrative workload
December 12, 2019 -
PR Newswire
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting
December 10, 2019 -
GlobeNewswire
Precision BioSciences Presents Updated Interim Clinical Data at the ASH Annual Meeting from Relapsed / Refractory NHL and B-ALL Patients Treated at Dose Levels 1 & 2 in the Ongoing Phase 1/2a Clinical Trial of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate
December 9, 2019 -
GlobeNewswire
Orchard Therapeutics Showcases Clinical Data at the 61st American Society of Hematology Annual Meeting
December 8, 2019 -
Business Wire
Beam Therapeutics Presents Preclinical Data for Complementary Base Editing Approaches for Hemoglobinopathies at ASH 2019
December 8, 2019 -
PR Newswire
Unum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual Meeting
December 7, 2019 -
PR Newswire
Protenus Named a 2019 Top Workplace in Baltimore by The Baltimore Sun
December 6, 2019 -
PR Newswire
PatientPing Announces Two Additions to its Enterprise Suite of Solutions
December 5, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-LAG-3 Monoclonal Antibody in China
December 5, 2019 -
PR Newswire
Benchling Joins the AWS Partner Network Global Startups Program
December 4, 2019 -
GlobeNewswire
Regenerative Medicine Advanced Therapy Designation Granted by FDA to ADP‑A2M4 for the Treatment of Synovial Sarcoma
December 3, 2019 -
PR Newswire
Owkin Teams up with NVIDIA and King’s College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning
December 2, 2019 -
PR Newswire
Innovent Biologics Announces FDA Acceptance of NDA for Pemigatinib in Patients with Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusions or Rearrangements
December 2, 2019 -
GlobeNewswire
Orchard Therapeutics Announces the Filing and Validation of Marketing Authorization Application by European Medicines Agency for OTL-200 for the Treatment of Metachromatic Leukodystrophy
December 2, 2019 -
ENTracker
PharmEasy secures $220M Round
November 28, 2019 -
GlobeNewswire
SK Life Science, Inc. Receives US FDA Approval for cenobamate tablets for the Treatment of Partial-Onset Seizures in Adults with Epilepsy
November 27, 2019 -
PR Newswire
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-PD-1/HER2 Bispecific Antibody in China
November 26, 2019 -
PR Newswire
TraceLink Partners with Saudi Azm to Help Pharmaceutical Manufacturers Comply with Saudi Arabia Aggregation Requirements
November 25, 2019 -
Business Wire
Wellframe Secures $20M in Funding to Advance Digital Health Management
November 19, 2019 -
GlobeNewswire
European Medicines Agency Grants Orchard Therapeutics Accelerated Assessment of OTL-200 for Patients with Metachromatic Leukodystrophy
November 18, 2019 -
Business Wire
Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells
November 18, 2019 -
BioSpace
Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
November 18, 2019 -
Business Wire
Devoted Health Named a 2019 Best Places To Work in Boston
November 15, 2019 -
PR Newswire
KLAS Research Recognizes PatientPing as a High Performing Emerging Healthcare IT Company
November 14, 2019 -
GlobeNewswire
Precision BioSciences Welcomes Healthcare Industry Expert, Kevin J. Buehler, to its Board of Directors
November 13, 2019 -
GlobeNewswire
Hua Medicine’s Pivotal Phase III Monotherapy Trial of Dorzagliatin, a Dual-Acting Glucokinase Modulator, Achieves Primary Efficacy Endpoint in Patients with Type 2 Diabetes
November 11, 2019 -
PR Newswire
Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965
November 11, 2019 -
BioSpace
Hua Medicine to Release Phase III 24-Weeks Topline Data of Dorzagliatin Monotherapy Trial (HMM0301) on November 12
November 8, 2019 -
GlobeNewswire
Tempest Therapeutics’ Oncology Programs Presented at Society of Immunotherapy for Cancer Annual Meeting
November 8, 2019 -
PR Newswire
TraceLink Ranked #298 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500™
November 7, 2019 -
GlobeNewswire
Orchard Therapeutics Reports Third Quarter 2019 Financial Results and Achievement of Key 2019 Milestones for Neurometabolic and Primary Immune Deficiencies Franchises
November 6, 2019 -
GlobeNewswire
Unum Therapeutics Presents Preclinical Data for BOXR1030 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 5, 2019 -
BioSpace
Checkmate Pharmaceuticals Presents Positive Clinical Data with CMP-001 at The 34th Annual Meeting of The Society for Immunotherapy of Cancer (SITC)
November 5, 2019 -
GlobeNewswire
Unum Therapeutics Announces Strategic Focus on Developing Best-in-Class Cellular Therapies for Solid Tumor Cancers
November 4, 2019 -
PR Newswire
Iora Primary Care Recognizes National Alzheimer’s Awareness and Family Caregivers Months with Educational Workshops Across the Country
November 4, 2019 -
Business Wire
Beam Therapeutics Announces Collaboration and Exclusive License Agreement with Prime Medicine for Prime Editing Technology
October 31, 2019 -
PR Newswire
Embark and VetBloom Collaborate to Create Inaugural Canine Genomics E-Learning Courses
October 31, 2019 -
PR Newswire
Promentis Pharmaceuticals Announces Positive Results for Phase 2A Study of SXC-2023 Targeting Novel Glutamatergic Mechanism and Completion of Enrollment for Phase 2 Trichotillomania Study
October 31, 2019 -
Business Wire
Checkmate Pharmaceuticals Announces Appointment of Kleem Chaudhary as Chief Business Officer
October 31, 2019 -
GlobeNewswire
Lumere’s Category Optimization Solution Named 2019 Chicago Innovation Award Winner
October 29, 2019 -
PR Newswire
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
October 26, 2019 -
PR Newswire
TraceLink Appoints Merck KGaA Thought Leader to Drive Strategy for Deployment of Advanced Analytics across Life Sciences Industry
October 24, 2019 -
Business Wire
Compass Therapeutics to Present Preclinical Data on a Novel PD-1/PD-L1 Bispecific Antibody and from its Proprietary Innate Cell Engager Platform at the 2019 SITC Meeting
October 24, 2019 -
dotmed
Ivenix partners with Iatric Systems to deliver auto-pump programming to MEDITECH hospitals
October 23, 2019 -
GlobeNewswire
Orchard Therapeutics Presents Data from OTL-200 in Patients with Metachromatic Leukodystrophy Using Cryopreservation
October 23, 2019 -
BioSpace
Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to Its Immuno-Oncology Scientific Advisory Board
October 22, 2019 -
PR Newswire
Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965
October 21, 2019 -
PR Newswire
Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma
October 20, 2019 -
PR Newswire
Insilico Medicine and ChemDiv form a strategic drug discovery service alliance
October 16, 2019 -
Business Wire
Bozeman Health Engages Kyruus to Support its Digital Transformation and Integrate Patient Access System-wide
October 15, 2019 -
BioSpace
Checkmate Pharmaceuticals Announces Additions to Management Team
October 15, 2019 -
GlobeNewswire
Ultragenyx Announces FDA Accepts New Drug Application for UX007 (triheptanoin) for Treatment of Long-chain Fatty Acid Oxidation Disorders
October 14, 2019 -
BioSpace
Menlo Therapeutics Presents Successful Phase 2 Clinical Trial Results of Serlopitant in Psoriasis at the European Academy of Dermatology and Venereology Meeting
October 11, 2019 -
PR Newswire
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors
October 10, 2019 -
PR Newswire
Protenus Focuses on Customers and Compliance With New Additions of Chief Customer Officer and Vice President of Legal
October 10, 2019 -
Business Wire
Beam Therapeutics Appoints Graham Cooper to Board of Directors
October 10, 2019 -
PR Newswire
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million
October 9, 2019 -
GlobeNewswire
Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies
October 9, 2019 -
Forbes
AI Startup Working To Target Cancer, Age-Related Disease Gets $37 Million Nod From Top VCs
October 9, 2019 -
Fierce Biotech
Owkin’s mesothelioma AI discovers new biomarkers from lung biopsy images
October 7, 2019 -
Business Wire
Lafayette General Health to Elevate Consumer Digital Experience and Launch Online Scheduling with Kyruus
October 7, 2019 -
CNBC
Private Medicare plan Devoted Health says it is the first to cover Apple Watch as a benefit
October 7, 2019 -
GlobeNewswire
Tempest Therapeutics Names Biopharmaceutical Executive Stephen Brady as President and Chief Operating Officer
October 7, 2019 -
PRWeb
Vitalware’s Tara Bradley Named Finalist in 16th Annual Stevie® Awards for Women in Business
October 7, 2019 -
VerveTx
Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer
October 3, 2019
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.